companydata.dkcompanydata.dk

FARMACEUTISK LABORATORIUM FERRING A/S: Financial statements 2014

CVR: 62664819

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

FARMACEUTISK LABORATORIUM FERRING A/S (CVR 62664819) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -2,567,000 compared with DKK -2,462,000 the year before. Equity in the 2014 report amounted to DKK 3,518,000. The solvency ratio was 5.6%.

Profit/Loss
DKK -2,567,000
Equity
DKK 3,518,000
Total Assets
DKK 62,430,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014---2.6M3.5M-
2013---2.5M6.1M-
2012---7.6M-58.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

FARMACEUTISK LABORATORIUM FERRING A/S: The 2013 annual report is outApr 3, 2014

FARMACEUTISK LABORATORIUM FERRING A/S has published its annual report for 2013. The net result was DKK -2,462,000.

FARMACEUTISK LABORATORIUM FERRING A/S appoints new auditorApr 1, 2014

As of April 1, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FARMACEUTISK LABORATORIUM FERRING A/S.

Auditor steps down at FARMACEUTISK LABORATORIUM FERRING A/SApr 1, 2014

As of April 1, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of FARMACEUTISK LABORATORIUM FERRING A/S.

About FARMACEUTISK LABORATORIUM FERRING A/S

FARMACEUTISK LABORATORIUM FERRING A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1956. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Marianne Kock. The board consists of Jeffrey Douglas McConaghy (chair), Marianne Kock and Pierre-Jerome Blain. The company is owned by Ferring B.V.. The company has 0 employees (2009). In 2025, the company reported a gross profit of DKK 751,000 and a net result of DKK 100,851,000 compared with DKK -4,904,000 the year before. Equity in the 2025 report amounted to DKK -206,358,000.

Source: annual report 2025, Danish Business Authority